Central Bank: dollarization in Armenia believed to abate this year

YEREVAN, February 14. /ARKA/. The Central Bank of Armenia says in its monetary policy program for the first quarter of this year that dollarization in the country’s money stock is expected to subside 4.2% in 2012.

The regulator says that to tame down dollarization it plans to increase cash on hand by 13.3% and deposits in national currency by 30%, while deposits in foreign currencies will be enlarged by 12.6%.

It means the ratio of the country’s dram base to GDP will rise 10%.

The central bank also says that money and dram stock will grow 17.6% and 21.1% respectively, and monetary base will grow 8%.
According to National Statistical Service of Armenia, the country’s monetary base grew 13.6% or by AMD 80.2 billion in December 2011, compared to the previous month, to AMD 671.3 billion.

Money stock grew 5.2% or by AMD 55.8 billion in December 2011, compared with November, to AMD 1127 billion. ($1 – AMD 388.62).-0—

spot_img

POPULAR

Armenian dram strengthens against US dollar and weakens against euro and ruble

YEREVAN, August 21. /ARKA/. The average market exchange rate of the US dollar to the Armenian dram on the Armenian foreign exchange market on August 21, 2026, fell by 0.1 point to 365.16 drams compared to August 20.

“Solis” CJSC’s bonds listed on Armenia Stock Exchange

YEREVAN, August 18. /ARKA/. The range of companies listed on the Armenia Stock Exchange (AMX) continues to expand, contributing to the development of the capital market and creating new opportunities for businesses.

New requirements for banks to manage risks of circumventing international sanctions come into effect in Armenia

YEREVAN, August 17. /ARКА/. As of August 12, 2026, new regulations for banks regarding the management of risks associated with evading international sanctions have been implemented in Armenia.

Armbanks Weekly Digest: Key Events in Armenia’s Financial Market (August 10-16)

YEREVAN, August 17. /ARKA/. Armenia's financial agenda last week focused on setting up payment and cryptocurrency infrastructure, capital market activity, and the parameters of the next stage of universal health insurance.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img